VACCINE AGAINST INFECTIOUS BOVINE KERATOCONJUNCTIVITIS BASED ON ANTIGENS OF Moraxella bovis and Moraxella bovoculi BACTERIA Russian patent published in 2016 - IPC A61K35/74 A61K33/06 A61K31/115 A61P31/04 

FIELD: veterinary science.

SUBSTANCE: invention is intended for prevention of infectious keratoconjunctivitis in cattle. As antigens vaccine contains inactivated suspension of cells of Moraxella bovis “G97-VNIVI” bacteria strains with concentration of 100-120 bln. m.c. at 1 cm³ and Moraxella bovoculi “SH-CH6 No.-DEP” with concentration of 100-120 bln. m.c. at 1 cm³ taken in equal proportions, on a physiological solution, as an adjuvant-6 % aluminium hydroxide gel, inactivator is formalin in the following components ratio per 1 l of the vaccine: suspension cell strain of bacteria Moraxella bovis “G97-VNIVI” with concentration of 100-120 bln. m.c. in 1 cm³, cm³ - 90.0-100.0; suspension cell strain of bacteria Moraxella bovoculi “SH-CH6 No.-DEP” with concentration of 100-120 bln. m.c. in 1 cm³, cm³ - 90.0-100.0; aluminium hydroxide gel 6 %, cm³ - 90.0-100.0; formalin, cm³ - 4.0-5.0; physiologic saline, l - 1.

EFFECT: invention is highly effective for preventing infectious keratoconjunctivitis in cattle.

1 cl, 3 tbl, 1 ex